Nagmeldin A Omer1, Yun Hu2, Abdulrahman A Idriss2, Halima Abobaker2, Zhen Hou2, Shu Yang2, Wenqiang Ma3, Ruqian Zhao2. 1. MOE Joint International Research Laboratory of Animal Health & Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China; Key Laboratory of Animal Physiology & Biochemistry, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China; College of Allied Medical Sciences, University of Nyala, Nyala, Sudan. 2. MOE Joint International Research Laboratory of Animal Health & Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China; Key Laboratory of Animal Physiology & Biochemistry, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China. 3. MOE Joint International Research Laboratory of Animal Health & Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China; Key Laboratory of Animal Physiology & Biochemistry, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P. R. China. Electronic address: wq8110@njau.edu.cn.
Abstract
In avian species, liver lipid metabolism plays an important role in egg laying performance. Previous studies indicate that betaine supplementation in laying hens improves egg production. However, it remains unclear if betaine improves laying performance by affecting hepatic lipid metabolism and what mechanisms are involved. We fed laying hens a 0.5% betaine-supplemented diet for 4 wks to investigate its effect on hepatic lipids metabolism in vivo and confirmed its mechanism via in vitro experiments using embryonic chicken hepatocytes. Results showed that betaine supplemented diet enhanced laying production by 4.3% compared with normal diet, accompanied with increased liver and plasma triacylglycerol concentrations (P < 0.05) in hens. Simultaneously, key genes involved in hepatic lipid synthesis, such as sterol regulatory element binding protein 1 (SREBP-1), fatty acid synthase, acetyl-CoA carboxylase, and stearoyl-CoA desaturase 1 (SCD1) were markedly upregulated at the mRNA level (P < 0.05). Western blot results showed that SREBP-1 and SCD1 protein levels were also increased (P < 0.05). Moreover, mRNA expression of main apolipoprotein components of yolk-targeted lipoproteins, apolipoprotein B (ApoB) and apolipoprotein-V1 (ApoV1), in addition to microsomal triglyceride transfer proteins, which is closely related to the synthesis and release of very-low density lipoprotein, were also markedly elevated (P < 0.05). Methylated DNA immunoprecipitation combined with PCR detects reduction of methylation levels in certain regions of the above gene promoters. Chromatin immunoprecipitation PCR assays showed increased binding of glucocorticoid receptor (GR) to SREBP1 and ApoB gene promoters. Similar results of ApoV1 gene expression were obtained from cultured hepatocytes treated with betaine. Additionally, betaine increased the expression of GR and some genes involved in methionine cycle in vitro. These results suggest that betaine supplementation could alter the expression of liver lipid synthesis and transport-related genes by modifying the methylation status and GR binding on their promoter and hence promote the synthesis and release of yolk precursor substances in the liver.
In avian species, liver lipid metabolism plays an important role in egg laying performance. Previous studies indicate that betaine supplementation in laying hens improves egg production. However, it remains unclear if betaine improves laying performance by affecting hepatic lipid metabolism and what mechanisms are involved. We fed laying hens a 0.5% betaine-supplemented diet for 4 wks to investigate its effect on hepatic lipids metabolism in vivo and confirmed its mechanism via in vitro experiments using embryonic chicken hepatocytes. Results showed that betaine supplemented diet enhanced laying production by 4.3% compared with normal diet, accompanied with increased liver and plasma triacylglycerol concentrations (P < 0.05) in hens. Simultaneously, key genes involved in hepatic lipid synthesis, such as sterol regulatory element binding protein 1 (SREBP-1), fatty acid synthase, acetyl-CoA carboxylase, and stearoyl-CoA desaturase 1 (SCD1) were markedly upregulated at the mRNA level (P < 0.05). Western blot results showed that SREBP-1 and SCD1 protein levels were also increased (P < 0.05). Moreover, mRNA expression of main apolipoprotein components of yolk-targeted lipoproteins, apolipoprotein B (ApoB) and apolipoprotein-V1 (ApoV1), in addition to microsomal triglyceride transfer proteins, which is closely related to the synthesis and release of very-low density lipoprotein, were also markedly elevated (P < 0.05). Methylated DNA immunoprecipitation combined with PCR detects reduction of methylation levels in certain regions of the above gene promoters. Chromatin immunoprecipitation PCR assays showed increased binding of glucocorticoid receptor (GR) to SREBP1 and ApoB gene promoters. Similar results of ApoV1 gene expression were obtained from cultured hepatocytes treated with betaine. Additionally, betaine increased the expression of GR and some genes involved in methionine cycle in vitro. These results suggest that betaine supplementation could alter the expression of liver lipid synthesis and transport-related genes by modifying the methylation status and GR binding on their promoter and hence promote the synthesis and release of yolk precursor substances in the liver.
The process of egg production requires a massive increase in triacylglycerol (TG) synthesis to support the energy demands of new yolk formation (Wu et al., 2013). In liver, de novo synthesized triglycerides are packaged into very-low density lipoprotein (VLDL) and used for yolk formation (Cherian, 2015, Li et al., 2017). Hepatic TG homeostasis, the balance between de novo lipogenesis and export of VLDL particles, is extremely important for egg production and chicken health (Liu et al., 2016). Nevertheless, the impact of induced hepatic lipogenesis on egg production is debatable.More than 90% of the de novo synthesis of fatty acids (FA) occurs in the liver of poultry. The key FA synthesis-related genes including fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and stearoyl-CoA desaturase 1 (SCD1) could be regulated by sterol regulatory element-binding protein-1 (SREBP1) (Choi and Ginsberg, 2011). Hepatic SCD1 is of considerable importance to monounsaturated FA synthesis and is upregulated at the onset of egg-laying in hens (Li et al., 2017). Apolipoprotein B (ApoB) and VLDL-apolipoprotein II, also named ApoV1, are major components of VLDL-yolk, the specialized avian lipoprotein produced by the liver and function to transport lipids to the ovary for yolk deposition (Chan et al., 1980, Kirchgessner et al., 1987). The expression levels of these 2 apolipoproteins are found to be dramatically elevated in laying hens compared with nonlaying (Li et al., 2017). Microsomal triglyceride transfer protein, an enzyme which is located in the lumen of the endoplasmic reticulum, plays a major role in the synthesis and secretion of VLDL particles from the liver (Wetteru et al., 1997). In sexually mature hens, all these enzymes are basically controlled by sex hormones, mainly estrogen (Speake et al., 1998, Walzem et al., 1999, Riegler et al., 2011). Although, nutritional factors may also play an essential role.Betaine is a naturally occurring micronutrient, chemically known as trimethylglycine. It was first reported in sugar beets, then later discovered in many products. In cells, betaine plays 2 critical roles, stabilizing osmolyte and donating methyl group to other biomolecules (Craig, 2004). Numerous studies in hens indicated that betaine supplementation improved the laying performance and egg production (Zou and Lu, 2002, Gudev et al., 2011, Xing and Jiang, 2012). Previously, we also reported improved egg production in betaine-supplemented hens which might be attributed to the activation of hepatic VTGII expression (Omer et al., 2018). However, whether the modulation of hepatic lipids metabolism induced by betaine might influence laying performance in hens is yet to be studied. Furthermore, glucocorticoid receptor (GR), which is thought to be involved in modulating lipids metabolism and TG homeostasis (Yu et al., 2010, Wang et al., 2012), was induced by dietary betaine in hens (Omer et al., 2018). Nevertheless, the correlation among betaine supplementation, hepatic GR expression, and hepatic lipogenesis is largely uncertain in hens.Betaine acts as a primary methyl donor for the epigenetic regulation of gene expression through DNA methylation (Anderson et al., 2012, Day and Kempson, 2016). Hypermethylation of the promoter regions leads to gene silencing because of blocking its accessibility by transcription machinery, whereas hypomethylation results in gene activation (Razin, 1998). Wang et al. reported decreasing hypermethylation pattern of hepatic MTTP gene promoter induced by a high-fat diet, which increased its mRNA expression, when male mice were fed betaine-supplemented diet (Wang et al., 2014). A study in laying hens abdominal fat revealed that betaine-supplemented diet increases FAS mRNA abundance and may affect the methylation status of its promoter (Xing and Jiang, 2012). Hu et al. reported that in ovo betaine injection induced SREBP1 and cholesterol metabolism-related genes expression in liver of newly hatched chicks (Hu et al., 2015). Nevertheless, it seems that betaine effect on lipids metabolism varies with animal species, sex, and physiological condition. Some studies concluded that the inhibition of hepatic FA synthesis as a mechanism by which betaine prevent or improve fatty liver syndrome (Song et al., 2007, Kathirvel et al., 2010, Xing et al., 2011).Therefore, we investigated the key gene expression involved in hepatic TG homeostasis, DNA methylation status of the promoter regions of the affected genes, and its binding activity of GR to further reveal the relationship between betaine supplementation and laying performance in hens.
Materials and methods
Animals and Treatment
As previously reported (Omer et al., 2018), one hundred and twenty 38-wk Rugao yellow breeders laying hens were randomly divided into 2 groups: control group (basal diet) and betaine group (basal diet supplemented with 0.5% pure betaine) as presented in Table 1. The betaine (75% purity) was purchased from the Skystone Feed Co., Ltd., Jiangsu, China. The laying performance was recorded daily throughout the 4-wk feeding period. Sixteen hens were randomly selected, weighed, and killed by rapid decapitation at the end of experiment. Blood samples were taken, and plasma was separated and stored at −20°C. Liver samples were dissected, snap frozen in liquid nitrogen then stored at −80°C.
Determination of Hepatic and Plasma Triglyceride Concentration
The liver and plasma concentrations of triglyceride were examined by an automatic biochemical analyzer (Beckman coulter, AU2700) using commercial assay kits (E1013 and E1003, Applygen Technologies Inc., Beijing, China) following the manufacturer's instructions.
Histological Analysis of Liver Tissue
Liver samples were fixed in 4% paraformaldehyde, paraffin-embedded, sectioned, and then stained with hematoxylin-eosin. For Oil Red staining frozen sections of liver were used.
In Vitro Experiment
Fertilized chicken eggs at embryonic day 17 (E17) were obtained from a local farm and artificially incubated for an additional 2 D at 37.5°C and 60% relative humidity. Embryos E19 were euthanized by decapitation to collect livers. Livers were pooled, digested, and filtrated to get hepatocytes. Then the cell pellet was suspended in M199 medium (Shanghai Basalmedia Technologies Co., Ltd., Shanghai, China), supplemented with 10% fetal bovine serum. Hepatocytes were seeded onto 6-well plates, 2 mL/well. The cells density was about 5.5 × 106 cells/well. The cells were incubated for 24 h at 37.8°C with 5% CO2 before dosing. Then, hepatocytes were treated for 24 h with vehicle control, 10 mmol betaine, 100 nM β-estradiol, or combination of 10 mmol betaine with 100 nM β-estradiol, in a basal medium supplemented with insulin-transferrin-selenium mix (ITS 1 mg/mL; Sigma-Aldrich, St Louis, MO) (2 mL/well). After 24 h of treatment, cells were directly harvested and used for the subsequent experiment.
Total RNA Isolation and Real-Time PCR
Total RNA was isolated from frozen hens liver samples and the embryonic hepatocytes using TRIzol reagent (Invitrogen, Carlsbad, CA) and then reverse-transcribed to cDNA by HiScript qRT SuperMix (Vazyme Biotech Co., Ltd., Nanjing, China). Diluted cDNA (1:50, vol/vol) was used for real-time PCR with QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems, Foster City, CA). β-actin and 18s rRNA were selected as internal controls for normalization. All primers including those used for qRT-PCR (Table 2) were synthesized by Genewiz (Suzhou, China). Data were analyzed using the method of 2−ΔΔCT (Livak and Schmittgen, 2001).
Nucleotide sequences of primers used for qRT-PCR.Abbreviations: ACC, acetyl-CoA carboxylase; APOB1, apolipoprotein B1; APOV1, apolipoprotein-V1; BHMT, betaine homocysteine methyltransferase; DNMT1, DNA (cytosine-5-)-methyltransferase 1; FAS, fatty acid synthase; GNMT, glycine-N-methyltransferase; GR, glucocorticoid receptor; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
Protein Extraction and Western Blotting
Total protein of the hen's liver was extracted from 40 mg frozen tissues as previously described (Cai et al., 2014a). For cell, total protein was extracted using a lysis buffer purchased from Nanjing Sunshine Biotechnology. In brief, the culture dish was washed by gentle immersion in cold PBS for 2 times. The cells were then scratched to 1.5 mL tubes and centrifuged for 5 min at 700 × g to remove the PBS. The pellet was dissolved in 200 μL cold lysis buffer supplemented with protease inhibitor cocktail and then subjected to ultrasonication to insure cells destruction. Following centrifugation at 12,000 × g for 10 min, the supernatant was collected in new 1.5 mL tubes. Nuclear protein was extracted by a special kit (Beyotime Biotechnology, Wuhan, China). Protein concentrations were measured using a Pierce BCA Protein Assay kit (No. 23225; Thermo Fisher Scientific, Rockford, IL). Western blot analysis for SREBP1 (14088-1-AP, Proteintech, Rosemont, IL, diluted 1:500), SCD1 (2438, Cell Signaling Technology, Danvers, MA, diluted 1:500), BHMT (15965-1-AP, Proteintech, diluted 1:200), DNMT1 (24206-1-AP, Proteintech, diluted 1:1,000), GNMT (18,790, Proteintech, diluted 1:500), GR and MAT2b (15952-1-AP, Proteintech, diluted 1:1,000) was carried out according to the recommended protocols provided by the manufacturers. β-actin (AP0060, Bioworld, Dublin, OH, diluted 1:10,000), β-tubulin (AP0064, Bioworld, diluted 1:5,000) and histone H1 (BS1655, Bioworld, diluted 1:500) were used as loading control. Images were captured using VersaDoc 4,000 MP system, and the band density was analyzed by Quantity One software (Bio-Rad Laboratories, Hercules, CA).
Methylated DNA Immunoprecipitation Analysis
In brief, liver samples were extracted to obtain high-quality genomic DNA and then sonicated to approximately 500 bp sized fragments. Fragmented DNA was heat-denatured, methylated to obtain the immunoprecipitated methylated DNA fractions using a mouse monoclonal antibody against 5-methyl cytosine (ab10805, Abcam, Cambridge, UK). The immune complexes were treated using the protein G agarose beads (No. Sc-2003, Santa Cruz Biotechnology, Santa Cruz, CA), then washed via digestion buffer containing proteinase K (No. P0021, Nanjing Sunshine Biotechnology Ltd., Nanjing, China) to obtain purified methylated DNA immunoprecipitation (MeDIP) DNA. A small aliquot of MeDIP DNA and control input DNA was used to amplify the proximal promoter sequence of chickenSREBP1, ACC, SCD1, FAS, and MTTP genes by real-time PCR with specific primers listed in Table 3. Data were normalized against the input and presented as the fold change in comparison to the average value of the control group.
Table 3
Nucleotide sequences of primers used for MeDIP-PCR.
Nucleotide sequences of primers used for MeDIP-PCR.Abbreviations: ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
Chromatin Immunoprecipitation Analysis
The glucocorticoid receptor element (GRE) binding sites are predicted on the promoter sequences of target genes (SREBP1, ACC, SCD1, FAS, MTTP, ApoB, and ApoV1) using the online software, PROMO (Messeguer et al., 2002, Farré et al., 2003). Chromatin immunoprecipitation (ChIP) analysis was performed as previously described (Cai et al., 2014b). In brief, liver samples were ground, suspended, cross-linked, and sonicated to obtain an average chromatin fragment size of 300–500 bp. Sheard chromatin was precleared, incubated overnight, and treated using protein A/G agarose beads to capture the immunoprecipitated complexes. Finally, DNA fragments were released from immunoprecipitated complexes via reverse cross-linking and then used as template for real-time PCR with specific primers (Table 4).
Table 4
Nucleotide sequences of primers used for ChIP-PCR.
Nucleotide sequences of primers used for ChIP-PCR.Abbreviations: ACC, acetyl-CoA carboxylase; APOB1, apolipoprotein B1; APOV1, apolipoprotein-V1; FAS, fatty acid synthase; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
Statistical Analysis
All data are presented as means ± SEM. Comparisons were performed using independent-samples t test and analysis of variance when applicable, with SPSS18.0 for Windows. The data were considered statistically significant when the P-value was less than 0.05.
Results
Laying Performance
Dietary betaine supplementation significantly enhanced egg-laying rate (P < 0.05) but did not affect body weight, average daily feed intake, and egg weight (Table 5).
Table 5
Production performance in laying hens.
Parameters
CON
BET
P-value
Initial body weight, kg
1.40 ± 0.01
1.41 ± 0.01
0.33
Final body weight, kg
1.42 ± 0.02
1.43 ± 0.02
0.60
Average daily feed intake, g/D
91.03 ± 1.18
95.95 ± 2.82
0.15
Average daily laying rate, %
80.19 ± 1.12
84.50 ± 0.96
0.03
Egg weight, g
43.09 ± 0.44
42.01 ± 0.41
0.31
Abbreviations: BET, betaine group; CON, control group.
Production performance in laying hens.Abbreviations: BET, betaine group; CON, control group.
Hepatic and Plasma Concentration of TG
Oil red staining showed increasing hepatic lipids droplet in hens supplemented with betaine (Figure 1A). Betaine supplementation markedly elevated hepatic and plasma concentration of TG (P < 0.05) (Figures 1B and 1C).
Figure 1
Plasma and liver concentration of TG and histological analysis of liver tissue. (A) Top: Hematoxylin and eosin (H&E) staining; middle and bottom: oil red staining. (B) Hepatic TG concentration. (C) Plasma TG concentration. Values are means ± SEM, *P < 0.05, compared with control (n = 8). Abbreviation: TG, triacylglycerol.
Plasma and liver concentration of TG and histological analysis of liver tissue. (A) Top: Hematoxylin and eosin (H&E) staining; middle and bottom: oil red staining. (B) Hepatic TG concentration. (C) Plasma TG concentration. Values are means ± SEM, *P < 0.05, compared with control (n = 8). Abbreviation: TG, triacylglycerol.
Hepatic Expression of Genes Involved in Fatty Acid Synthesis and VLDL Formation and Export
Dietary betaine greatly enhanced (P < 0.05) the mRNA and protein level of SREBP-1 and SCD1 in addition to enhancing mRNA expression of FAS and ACC (Figures 2A and 2C). These genes are key regulators for hepatic lipogenesis. Meanwhile, betaine supplementation upregulated MTTP, ApoB, and ApoV1 expression at the mRNA level (P < 0.05), which involved in TG synthesis and export to extrahepatic tissues (Figure 2B). Protein expression of these genes was not carried out because of a lack of chicken specific antibodies.
Figure 2
Effect of betaine supplemented diet on the expression of main genes involved in hepatic lipogenesis and TG and VLDL formation and export in hens. (A) mRNA expression of SREBP1, ACC, SCD1, and FAS. (B) mRNA expression of ApoB, ApoV1, and MTTP. (C) Protein expression of SREBP1 and SCD1. Values are means ± SEM, *P < 0.05, compared with control (n = 8). Abbreviations: ACC, acetyl-CoA carboxylase; ApoB, apolipoprotein B; ApoV1, apolipoprotein-V1; FAS, fatty acid synthase; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
Effect of betaine supplemented diet on the expression of main genes involved in hepatic lipogenesis and TG and VLDL formation and export in hens. (A) mRNA expression of SREBP1, ACC, SCD1, and FAS. (B) mRNA expression of ApoB, ApoV1, and MTTP. (C) Protein expression of SREBP1 and SCD1. Values are means ± SEM, *P < 0.05, compared with control (n = 8). Abbreviations: ACC, acetyl-CoA carboxylase; ApoB, apolipoprotein B; ApoV1, apolipoprotein-V1; FAS, fatty acid synthase; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
MeDIP Analysis for DNA Methylation Status on the Promoter of Affected Genes
Schematic diagram of promoter sequences of chickenSREBP1, ACC, FAS, SCD1, and MTTP are shown in Figures 3A–3E. Four segments (designated S1-S4) from the promoter of each gene were analyzed with MeDIP-PCR. Betaine supplementation markedly (P < 0.05) induced hypermethylation of S1 and S4 of SREBP1 promoter (Figure 3A), S1 and S2 of ACC promoter (Figure 3B), S1 and S2 of FAS promoter (Figure 3C), S1 and S2 of SCD1 promoter (Figure 3D), and S3 of MTTP promoter (Figure 3E). MeDIP for ApoB and ApoV1 genes was not performed because their promoter sequences contain few CpGs, which make them difficult to construct primers for MeDIP-PCR.
Figure 3
Methylation status on the promoter of SREBP1, ACC, FAS, SCD, and MTTP genes in the liver of hens detected by MeDIP-PCR. (A) Left: DNA methylation status on 4 segments (S) of SREBP1 promoter; right: schematic diagram showing the amplified segments and their sequences. (B) Left: DNA methylation status on 4 segments of ACC promoter; right: schematic diagram showing the amplified segments and their sequences. (C) Left: DNA methylation status on 4 segments of FAS promoter; right: schematic diagram showing the amplified segments and their sequences. (D) Left: DNA methylation status on 4 segments of SCD promoter; right: schematic diagram showing the amplified segments and their sequences. (E) Left: DNA methylation status on 4 segments of MTTP promoter; right: schematic diagram showing the amplified segments and their sequences. Values are means ± SEM, *P < 0.05, compared with control (n = 3). Abbreviations: ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; MeDIP, methylated DNA immunoprecipitation; MTTP, microsomal triglyceride transfer protein; SCD, stearoyl-CoA desaturase; SREBP1, sterol regulatory element-binding protein-1.
Methylation status on the promoter of SREBP1, ACC, FAS, SCD, and MTTP genes in the liver of hens detected by MeDIP-PCR. (A) Left: DNA methylation status on 4 segments (S) of SREBP1 promoter; right: schematic diagram showing the amplified segments and their sequences. (B) Left: DNA methylation status on 4 segments of ACC promoter; right: schematic diagram showing the amplified segments and their sequences. (C) Left: DNA methylation status on 4 segments of FAS promoter; right: schematic diagram showing the amplified segments and their sequences. (D) Left: DNA methylation status on 4 segments of SCD promoter; right: schematic diagram showing the amplified segments and their sequences. (E) Left: DNA methylation status on 4 segments of MTTP promoter; right: schematic diagram showing the amplified segments and their sequences. Values are means ± SEM, *P < 0.05, compared with control (n = 3). Abbreviations: ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; MeDIP, methylated DNA immunoprecipitation; MTTP, microsomal triglyceride transfer protein; SCD, stearoyl-CoA desaturase; SREBP1, sterol regulatory element-binding protein-1.
ChIP Analysis for GR Binding on the Promoter of Lipogenic Genes
Schematic diagram of promoter sequences of SREBP1 and ApoB are shown in Figures 4A and 4B, respectively. Dietary betaine significantly (P < 0.05) affect GR binding to GRE at promoter regions of SREBP1 and ApoB gene (Figure 4C). Other genes were not affected by betaine.
Figure 4
GR binding to the promoter of affected genes. (A) Schematic diagram showing the promoter sequences of chicken SREBP1 gene. (B) Schematic diagram showing the promoter sequences of chicken ApoB gene. (C) ChIP assays of GR binding on the promoter of SREBP1, ACC, SCD1, FAS, MTTP, ApoB, and ApoV1. Values are means ± SEM, *P < 0.05, compared with control (n = 3). Abbreviations: ACC, acetyl-CoA carboxylase; APOB1, apolipoprotein B1; APOV1, apolipoprotein-V1; FAS, fatty acid synthase; GR, glucocorticoid receptor; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
GR binding to the promoter of affected genes. (A) Schematic diagram showing the promoter sequences of chickenSREBP1 gene. (B) Schematic diagram showing the promoter sequences of chickenApoB gene. (C) ChIP assays of GR binding on the promoter of SREBP1, ACC, SCD1, FAS, MTTP, ApoB, and ApoV1. Values are means ± SEM, *P < 0.05, compared with control (n = 3). Abbreviations: ACC, acetyl-CoA carboxylase; APOB1, apolipoprotein B1; APOV1, apolipoprotein-V1; FAS, fatty acid synthase; GR, glucocorticoid receptor; MTTP, microsomal triglyceride transfer protein; SCD1, stearoyl-CoA desaturase 1; SREBP1, sterol regulatory element-binding protein-1.
Effect of Betaine on the Expression of ApoV1, GR, and Methionine Cycle-Related Genes In Vitro
Embryonic hepatocytes were treated with β-estradiol (E2) to initiate the synthesis of ApoV1 because its expression is dependent on estrogen. Betaine together with E2 have a maximal effect on ApoV1 expression than E2 alone (Figure 5A). Betaine supplementation greatly (P < 0.05) enhanced GR expression at the mRNA and protein levels, whereas E2 treatment had no effect (Figures 5B and 5C, respectively). Hepatocytes treated with betaine, but not E, had significantly (P < 0.05) higher mRNA and protein level of genes involved in liver methionine cycle named BHMT, GNMT, and DNMT1 (Figures 5D and 5E). The expression of MAT2b was not changed by either betaine or E2.
Figure 5
Effect of betaine on the expression of ApoV1, GR, and methionine cycle related genes in vitro. (A) mRNA expression of ApoV1, (B) mRNA expression of GR. (C) Protein expression of GR. (D) mRNA expression of BHMT, GNMT, DNMT1, MAT2b. (E) Protein expression of BHMT, GNMT, DNMT1, MAT2b. Values are means ± SEM, different letters above the bars indicate significantly different mean value at P < 0.05 compared with control, *P < 0.05, **P < 0.01, (n = 3). ND: Ct was not detectable. Abbreviations: APOV1, apolipoprotein-V1; BHMT, betaine homocysteine methyltransferase; DNMT1, DNA (cytosine-5-)-methyltransferase 1; GNMT, glycine-N-methyltransferase; GR, glucocorticoid receptor; MAT2b, methionine adenosyltransferase 2 subunit beta; MTTP, microsomal triglyceride transfer protein.
Effect of betaine on the expression of ApoV1, GR, and methionine cycle related genes in vitro. (A) mRNA expression of ApoV1, (B) mRNA expression of GR. (C) Protein expression of GR. (D) mRNA expression of BHMT, GNMT, DNMT1, MAT2b. (E) Protein expression of BHMT, GNMT, DNMT1, MAT2b. Values are means ± SEM, different letters above the bars indicate significantly different mean value at P < 0.05 compared with control, *P < 0.05, **P < 0.01, (n = 3). ND: Ct was not detectable. Abbreviations: APOV1, apolipoprotein-V1; BHMT, betaine homocysteine methyltransferase; DNMT1, DNA (cytosine-5-)-methyltransferase 1; GNMT, glycine-N-methyltransferase; GR, glucocorticoid receptor; MAT2b, methionine adenosyltransferase 2 subunit beta; MTTP, microsomal triglyceride transfer protein.
Discussion
In the current study, betaine supplementation enhanced egg laying rate accompanied with increased plasma and liver TG concentration and induced hepatic mRNA expression of the major lipogenic genes, SREBP1, ACC, FAS, and SCD, as well as MTTP, APOB, and APOV1 which are involved in TG synthesis and export. In vitro experiments revealed that betaine treated cells had higher expression of GR, APOV1, and the methyl-transfer enzymes BHMT, GNMT, and DNMT1.In laying hens, the physiological mechanism of egg formation requires the synthesis of yolk precursors, VTG, and VLDL-yolk in the liver (Vézina et al., 2003). Previously, we reported activation of hepatic VTGII expression plays a role in improving egg production in betaine-fed laying hens (Omer et al., 2018). Similar to other studies, our study also revealed an increase liver synthesis of FA and TG during egg laying in birds to maintain the demand for yolk formation (Furuse et al., 1991, Nys and Guyot, 2011).However, part of our results is contradicted with other studies in mice and rats, which concluded inhibiting lipogenesis as a result of betaine administration. In apolipoprotein E–deficient mice, Wang et al. reported that betaine reduced hepatic TG and alter the expression of hepatic lipid metabolism-related genes and especially reduced the expression of FAS (Wang et al., 2013). Another study revealed that betaine significantly attenuated the high-sucrose diet–induced hepatic steatosis which was associated with reduced hepatic lipogenic enzyme activities and gene expression in mice (Song et al., 2017). In rats, Ahn et al. reported that inhibition of lipid synthesis was one of the factors responsible for the antisteatotic activity of betaine (Ahn et al., 2015). It is noticed that most of these studies were conducted in male rather than female animals. Another observation is the use of induced hepatic steatosis model and trying to alleviate the change with betaine.Yet, our data indicating betaine enhanced hepatic lipid export and increased serum TG were in line with some studies in human and rats. For instance, Olthof et al. reported increasing blood TG concentrations in healthy human subject when betaine supplemented orally for 6 wks (Olthof et al., 2005). Sparks et al. reported increased hepatic ApoB mRNA level accompanied by higher serum concentration of TG and ApoB in rats fed betaine-supplemented diet (Sparks et al., 2006). Xu et al. and Ahn et al. stated that betaine improved liver lipid accumulation via increasing hepatic lipid exportation and FA oxidation in rats given high-fat diet (Ahn et al., 2015, Xu et al., 2015). Nevertheless, sex differences, physiological status, diet composition, experimental condition, organ specificity, as well as species differences should be considered when dealing with the effect of betaine on lipids metabolism.We observed increased oil droplets in the liver section of betaine fed hens. Again this result disagrees with other findings assumed hypolipidimic effect of betaine. But it is in agreement with Hayes et al. (Hayes et al., 2003) who observed increased fat droplets in rat hepatocytes following betaine intake. He suggested that betaine might stimulate both synthesis and secretion of VLDL. However, owing to a limitation in the protein supply, there was a brake on apolipoprotein formation. The consequence leads to an imbalance between synthesis and export which lead to increasing fat droplets in the liver. It is worth to do a further in-depth investigation to test the above hypothesis with different conditions, such as higher dietary protein level.In the present study, MeDIP results showed that betaine supplementation lowered the methylation status of the promoter region of target genes. It is not new phenomenon that betaine as a methyl donor, induced promoter hypomethylation. Previously, we showed that betaine reduced the methylation status of the GR gene promoter (Omer et al., 2018). Moreover, Wang et al. reported that addition of betaine decreased methylation level of hepatic PPARα promoter in mice and suggested that betaine selectively decrease the methylation status of certain genes involved in lipid metabolism (Wang et al., 2013). CpG hypomethylation of gene promoter may promote the binding activity of transcription factor to its specific response element (Moore ey al., 2013). In fact, hypomethylation on one of the analyzed segment of SREBP1 gene promoter was matched by a predicted GRE and might contribute to the increased GR binding, which was detected by ChIP method in the liver of betaine-fed hens. Glucocorticoid receptor is known regulator of several genes encoding enzymes in FA and TG synthesis (Wang et al., 2012). Furthermore, apart from GR effect, SREBP1 alone is well-known master regulator of lipids homeostasis (Horton et al., 2002, Eberlé et al., 2004).This study demonstrated that dietary betaine supplementation induced hepatic lipogenesis as well as TG formation and VLDL export in laying hens. These changes were associated with alteration in the expression, promoter methylation, and GR binding to some genes involved. Our findings suggested a distinct mechanism for improved eggs production by betaine supplementation in hens. However, further studies are necessary to determine the limitation regarding timing and dose, in addition to impact of treatment on animal health and welfare.
Authors: Domènec Farré; Romà Roset; Mario Huerta; José E Adsuara; Llorenç Roselló; M Mar Albà; Xavier Messeguer Journal: Nucleic Acids Res Date: 2003-07-01 Impact factor: 16.971
Authors: Chi-Yi Yu; Oleg Mayba; Joyce V Lee; Joanna Tran; Charlie Harris; Terence P Speed; Jen-Chywan Wang Journal: PLoS One Date: 2010-12-20 Impact factor: 3.240
Authors: Kay Boulton; Peter W Wilson; Valerie R Bishop; Jonathan H Perez; Toby Wilkinson; Kris Hogan; Natalie Z M Homer; Christelle Robert; Jacqueline Smith; Simone L Meddle; Ian C Dunn; Kellie Watson Journal: Sci Rep Date: 2021-10-26 Impact factor: 4.379